About
About WIN-Partners Co., Ltd
WIN-Partners Co., Ltd., through its subsidiaries, engages in the sales of medical equipment in Japan. The company offers PTCA balloon catheters and intravascular ultrasound diagnostic catheters for Ischemic heart disease-related; cardiac rhythm management, includes space makers, implantable cardioverter-defibrillators, implantable cardioverter-defibrillators with biventricular pacing, catheters for electrophysiological testing, and catheters for myocardial ablation; and stent grafts, transcatheter bioprosthetic valves, artificial blood vessels, heart-lung machines for cardiovascular surgery. It also provides PTA balloon catheters, peripheral vascular stents, and embolization coils to treat peripheral vascular and cerebrovascular diseases; and brain surgery-related products. In addition, the company offers various medical equipment such as X-ray angiography equipment, computed tomography equipment, magnetic resonance imaging equipment, and anesthesia machines; insulin pump, continuous glucose monitor, blood pressure transducer set, and blood pressure monitoring tubing. WIN-Partners Co., Ltd. was incorporated in 2013 and is headquartered in Chuo, Japan.
Visit company website
5 years, 6 months ago
WIN-Partners Co., Ltd is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
WIN-Partners Co., Ltd's total revenue rose by 7.4% to $17B since the same quarter in the previous year.
Its net income has increased by 5.0% to $423M since the same quarter in the previous year.
Based on the above factors, WIN-Partners Co., Ltd gets an overall score of 3/5.